IL296093A - Use of compounds in the treatment of fungal infections - Google Patents
Use of compounds in the treatment of fungal infectionsInfo
- Publication number
- IL296093A IL296093A IL296093A IL29609322A IL296093A IL 296093 A IL296093 A IL 296093A IL 296093 A IL296093 A IL 296093A IL 29609322 A IL29609322 A IL 29609322A IL 296093 A IL296093 A IL 296093A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- solvate
- hydrate
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062985274P | 2020-03-04 | 2020-03-04 | |
| PCT/US2021/020471 WO2021178406A1 (en) | 2020-03-04 | 2021-03-02 | Use of compounds in the treatment of fungal infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL296093A true IL296093A (en) | 2022-11-01 |
Family
ID=77612811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL296093A IL296093A (en) | 2020-03-04 | 2021-03-02 | Use of compounds in the treatment of fungal infections |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12521406B2 (https=) |
| EP (1) | EP4114405A4 (https=) |
| JP (1) | JP2023516648A (https=) |
| KR (1) | KR20220148881A (https=) |
| CN (1) | CN115515599A (https=) |
| AU (1) | AU2021230529B2 (https=) |
| BR (1) | BR112022017653A2 (https=) |
| CA (1) | CA3174065A1 (https=) |
| IL (1) | IL296093A (https=) |
| MX (1) | MX2022010804A (https=) |
| WO (1) | WO2021178406A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3187268A1 (en) * | 2020-06-17 | 2021-12-23 | Amplyx Pharmaceuticals, Inc. | Compounds and methods for treating fungal infections |
| CN116687929B (zh) * | 2023-06-16 | 2026-04-28 | 山东省妇幼保健院 | 血根碱在制备防治临床罕见真菌相关感染性疾病药物中的应用 |
| WO2026020112A1 (en) * | 2024-07-19 | 2026-01-22 | Sun Pharmaceutical Industries, Inc. | Oral formulations of deuruxolitinib |
| CN119915948B (zh) * | 2025-04-02 | 2025-07-08 | 天津辰欣药物研究有限公司 | 一种小分子真菌肌醇酰基转移酶1抑制剂原料药中致突变杂质的分析方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8513287B2 (en) | 2007-12-27 | 2013-08-20 | Eisai R&D Management Co., Ltd. | Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same |
| EP2345641A1 (en) | 2009-12-29 | 2011-07-20 | Polichem S.A. | New secondary 8-hydroxyquinoline-7-carboxamide derivatives |
| EP2636409A1 (en) * | 2010-11-05 | 2013-09-11 | Eisai R&D Management Co., Ltd. | Combined pharmaceutical composition as antifungal agent |
| IL275121B2 (en) * | 2017-12-07 | 2025-11-01 | Amplyx Pharmaceuticals Inc | Heterocycle substituted pyridine derivative antifungal agents |
| WO2020047510A1 (en) | 2018-08-31 | 2020-03-05 | Amplyx Pharmaceuticals, Inc. | Compounds and methods for treating fungal infections |
| CA3187268A1 (en) | 2020-06-17 | 2021-12-23 | Amplyx Pharmaceuticals, Inc. | Compounds and methods for treating fungal infections |
-
2021
- 2021-03-02 MX MX2022010804A patent/MX2022010804A/es unknown
- 2021-03-02 WO PCT/US2021/020471 patent/WO2021178406A1/en not_active Ceased
- 2021-03-02 KR KR1020227034025A patent/KR20220148881A/ko not_active Ceased
- 2021-03-02 BR BR112022017653A patent/BR112022017653A2/pt unknown
- 2021-03-02 CA CA3174065A patent/CA3174065A1/en active Pending
- 2021-03-02 AU AU2021230529A patent/AU2021230529B2/en active Active
- 2021-03-02 IL IL296093A patent/IL296093A/en unknown
- 2021-03-02 US US17/908,079 patent/US12521406B2/en active Active
- 2021-03-02 JP JP2022552405A patent/JP2023516648A/ja active Pending
- 2021-03-02 EP EP21765099.3A patent/EP4114405A4/en active Pending
- 2021-03-02 CN CN202180033043.8A patent/CN115515599A/zh active Pending
-
2025
- 2025-12-15 US US19/420,144 patent/US20260102419A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20260102419A1 (en) | 2026-04-16 |
| CA3174065A1 (en) | 2021-09-10 |
| AU2021230529A1 (en) | 2022-09-29 |
| NZ792042A (en) | 2025-09-26 |
| JP2023516648A (ja) | 2023-04-20 |
| AU2021230529B2 (en) | 2024-09-05 |
| EP4114405A4 (en) | 2024-03-13 |
| WO2021178406A1 (en) | 2021-09-10 |
| KR20220148881A (ko) | 2022-11-07 |
| US12521406B2 (en) | 2026-01-13 |
| EP4114405A1 (en) | 2023-01-11 |
| US20230102036A1 (en) | 2023-03-30 |
| CN115515599A (zh) | 2022-12-23 |
| BR112022017653A2 (pt) | 2022-10-18 |
| MX2022010804A (es) | 2023-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL296093A (en) | Use of compounds in the treatment of fungal infections | |
| JP7793681B2 (ja) | 真菌感染症を処置するための化合物および方法 | |
| KR20220074915A (ko) | 호산구성 식도염을 치료하고 칸디다증을 감소시키는 방법 | |
| WO2016131100A1 (en) | Methods of treating infectious diseases | |
| US20020193369A1 (en) | Antifungal compounds and uses therefor | |
| IL297334A (en) | Eclitasertib for use in the treatment of disorders associated with systemic hyperinflammatory responses | |
| US20200253959A1 (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases | |
| US20050282873A1 (en) | Epothilone derivative for the treatment of hepatoma and other cancer diseases | |
| CN110494140A (zh) | 用于自闭症谱系障碍药物治疗的方法 | |
| AU2021293911B2 (en) | Compounds and methods for treating fungal infections | |
| JP2002522392A (ja) | 低下された消化管毒性を有するカンプトテシン誘導体の使用 | |
| JP2011517678A (ja) | 過活動膀胱の治療のためのウデナフィル、およびアルフゾシンまたはオキシブチニンの組み合わせの使用 | |
| RU2805930C1 (ru) | Использование соединений при лечении грибковых инфекций | |
| JP2024069370A (ja) | 有効成分であるイサブコナゾール又はそのプロドラッグを含有する真菌症治療及び／又は予防剤 | |
| Groll et al. | Fungal infections in pediatric patients | |
| US11246857B2 (en) | Anti-fungal inhibitors | |
| RU2824066C1 (ru) | Соединения и способы для лечения грибковых инфекций | |
| HK40086224A (zh) | 化合物在真菌感染的治疗中的用途 | |
| HK40085944A (en) | Compounds and methods for treating fungal infections | |
| Johnson et al. | Echinocandins for prevention and treatment of invasive fungal infections | |
| CN119522109A (zh) | 用于钙调磷酸酶抑制剂的间歇性给药的组合物 | |
| WO2019023175A1 (en) | PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE AND NEOSTIGMINE AND AN ANTAGONIST NK-1 FOR THE TREATMENT OF SEVERE MYASTHENIA |